Raymond James & Associates’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,734	Closed	-$169K	–	3820
2022 Q4	$169K	Buy	+14,734	New	+$169K	﹤0.01%	3481
2021 Q4	–	Sell	-18,283	Closed	-$263K	–	3974
2021 Q3	$263K	Sell	18,283 -889	-5%	-$12.8K	﹤0.01%	3488
2021 Q2	$303K	Buy	+19,172	New	+$303K	﹤0.01%	3411